BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors.

Autor: Rigby M; Bicycle TX Ltd., Cambridge, United Kingdom., Bennett G; Bicycle TX Ltd., Cambridge, United Kingdom., Chen L; Bicycle TX Ltd., Cambridge, United Kingdom., Mudd GE; Bicycle TX Ltd., Cambridge, United Kingdom., Harrison H; Amphista Therapeutics, The Cori Building, Cambridge, United Kingdom., Beswick PJ; Bicycle TX Ltd., Cambridge, United Kingdom., Van Rietschoten K; Bicycle TX Ltd., Cambridge, United Kingdom., Watcham SM; Kymab Ltd., The Bennet Building, Babraham Research Campus, Cambridge, United Kingdom., Scott HS; Bicycle TX Ltd., Cambridge, United Kingdom., Brown AN; Bicycle TX Ltd., Cambridge, United Kingdom., Park PU; Orum Therapeutics, Cambridge, Massachusetts., Campbell C; Bicycle Therapeutics, Inc., Lexington, Massachusetts., Haines E; Ikena Oncology, Boston, Massachusetts., Lahdenranta J; Bicycle Therapeutics, Inc., Lexington, Massachusetts., Skynner MJ; Bicycle TX Ltd., Cambridge, United Kingdom., Jeffrey P; Bicycle TX Ltd., Cambridge, United Kingdom., Keen N; Bicycle Therapeutics, Inc., Lexington, Massachusetts., Lee K; Bicycle TX Ltd., Cambridge, United Kingdom.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Dec 02; Vol. 21 (12), pp. 1747-1756.